Position in INCY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$20,793,555
+$3,437,098 QoQ
Shares Held
220,926
+25.7% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Korea Investment CORP holds $256,163,456 across 7 Biotechnology names. INCY ranks #4 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
201,168 | $89,829,558 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
200,321 | $66,280,209 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
73,063 | $56,451,396 | |
| 4 | INCY |
Incyte Corp
This page
|
220,926 | $20,793,555 | |
| 5 | RPRX |
Royalty Pharma plc
|
219,972 | $10,552,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
66,461 | $6,463,332 | |
| 7 | INSM |
INSMED Inc
|
35,429 | $5,793,350 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,793,555 | 220,926 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $17,356,457 | 175,726 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $19,449,138 | 229,326 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,381,670 | 79,026 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,144,624 | 151,026 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,753,811 | 68,826 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,881,788 | 58,726 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,337,505 | 121,041 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $13,563,417 | 238,080 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $14,867,667 | 236,784 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,445,977 | 94,270 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,480,443 | 71,975 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $28,930,186 | 400,307 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $18,673,436 | 232,488 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,019,591 | 90,330 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,637,132 | 61,039 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,257,604 | 66,200 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,920,160 | 162,400 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $11,107,970 | 161,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $18,559,078 | 220,600 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,429,594 | 42,200 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,496,866 | 51,700 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $5,375,426 | 59,900 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,036,881 | 77,300 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $4,510,968 | 61,600 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||